About Satyarx Pharma Innovations LLP
Data last updated:
Satyarx Pharma Innovations LLP was a limited liability partnership (LLP) based in Hyderabad, Telangana, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 November 2019.
The LLP was registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAQ-9451.
The LLP had a total obligation of contribution of ₹1 Cr. It was led by designated partners Satyanarayana Murthy Chavali and Saroja Chavali.
Its latest statement of accounts is for the year ended 31 March 2020. The registered office was at 8.2.293/82/A/408 Road No 22A Jublee Hills, Hyderabad, Telangana, India – 500033.
The LLP is associated with 1 brand: SATYA Pharma Innovations.
The last known website on record is satyarx.com.
Company details
Contact details
Satyarx Pharma Innovations LLP's registered office is in Hyderabad, Telangana.
- Registered Address8.2.293/82/A/408 Road No 22A Jublee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Satyarx Pharma Innovations operates one associated brand: SATYA Pharma Innovations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops innovative small molecule technologies for cancer treatment. | satyarx.com |
Financials of Satyarx Pharma Innovations LLP
FY 2020 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2019-20 |
|---|---|
| Income and Expenditure | |
| Turnover | |
| Other Income | |
| Total Income | |
| Purchases and Direct Costs | |
| Personnel Expenses | |
| Administrative Expenses | |
| Interest | |
| Depreciation | |
| Total Expenses | |
| Profit Before Tax | |
| Tax | |
| Profit After Tax | |
| Profit Transferred to Partners | |
| Assets and Liabilities | |
| Partners' Contribution | |
| Reserves and Surplus | |
| Secured Loans | |
| Unsecured Loans | |
| Trade Payables | |
| Other Liabilities and Provisions | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Loans and Advances | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Statement of Account and Solvency | FY 2019-20 |
|---|---|
| Profitability | |
| Net Profit Margin | |
| Return on Partners' Funds | |
| Return on Assets | |
| Liquidity and Debt | |
| Current Ratio | |
| Debt to Partners' Funds | |
| Interest Coverage | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Turnover Growth | |
| Profit Growth | |
To see the full financial statements and ratios of Satyarx Pharma Innovations LLP, buy the company report.
Designated partners of Satyarx Pharma Innovations LLP
Satyarx Pharma Innovations has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Murthy Chavali Also directs: Satyatx Pharma Services LLP, Vijaya Diagnostic Centre Limited, Shadkala Pharma India Private Limited and 1 more | Designated Partner | 04 Nov 2019 | 7 Years 0 Months | As last reported |
| Saroja Chavali | Designated Partner | 04 Nov 2019 | 7 Years 0 Months | As last reported |
Legal cases
No court or tribunal cases involving Satyarx Pharma Innovations LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyarx Pharma Innovations LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Satyarx Pharma Innovations LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Satyarx Pharma Innovations LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Saroja Chavali was appointed as Designated Partner on 04 Nov 2019.
Frequently asked questions
Satyarx Pharma Innovations has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Satyarx Pharma Innovations was a limited liability partnership based in Hyderabad, Telangana, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 04 November 2019 and is registered under LLPIN AAQ-9451. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Satyarx Pharma Innovations is AAQ-9451. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Satyarx Pharma Innovations had 2 designated partners:
- Satyanarayana Murthy Chavali - Designated Partner
- Saroja Chavali - Designated Partner
Satyarx Pharma Innovations was incorporated on 04 November 2019. It is registered with the Registrar of Companies, Hyderabad.
Satyarx Pharma Innovations can be reached through the website satyarx.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Satyarx Pharma Innovations is at 8.2.29382A408 Road No 22A Jublee Hills, Hyderabad, Telangana, India – 500033.
The latest financial statements of Satyarx Pharma Innovations on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 March 2020. Year-wise statements from FY 2020 are in the company report.
Satyarx Pharma Innovations operated in the pharma industry, in the drug formulation and development segment.
Saroja Chavali was appointed as Designated Partner on 04 Nov 2019. Satyanarayana Murthy Chavali was appointed as Designated Partner on 04 Nov 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
